Fatty Liver Disease Is Rising in Non-Drinking Indians: Causes, Risks, and What to Do
Aishwarya Kapoor | Times Life Bureau | Sept 02, 2026, 07:02 IST
Fatty Liver Disease Is Rising in Non-Drinking Indians: Causes, Risks, and What to Do
Image credit : Times Life Bureau
Fatty liver disease is no longer a drinker's diagnosis. Across Indian cities, people who have never touched alcohol are being told their liver is in trouble, and the culprits are maida, desk jobs, and a blood sugar story that starts years before any symptom appears. NAFLD is quiet, common, and almost entirely driven by diet and insulin resistance.
The numbers are not small
What maida and white rice are actually doing
The problem is not carbohydrates as a category. Traditional Indian diets built around millets, legumes, and whole grains digest slowly and give the liver time to manage the glucose load. The shift happened when refined grain products became cheaper and more convenient than whole-grain alternatives, a change that accelerated through the 1990s and 2000s as processed food distribution reached tier-two and tier-three cities.
Desk jobs and visceral fat
Visceral fat, the fat stored around abdominal organs rather than under the skin, is metabolically active in a way subcutaneous fat is not. It releases free fatty acids directly into the portal vein, which drains straight into the liver. Indian adults tend to accumulate visceral fat at lower BMI thresholds than European populations, a pattern documented in research from the All India Institute of Medical Sciences, which found significant metabolic risk in Indian adults with BMI values that Western guidelines classify as normal. A person who appears lean by standard measures can still carry enough visceral fat to drive fatty liver disease.
Insulin resistance is the engine
This is why fatty liver in non-drinkers is fundamentally a glucose and insulin story. The liver is downstream of every meal. When blood sugar management is poor, the liver absorbs the consequences.
What actually changes the trajectory
Periodic liver function tests and an abdominal ultrasound are the standard screening tools. An ALT (alanine aminotransferase) level persistently above 40 U/L in the absence of alcohol use is a signal worth investigating. Most general physicians in India now include it in routine health panels, but many patients still do not follow up on mildly elevated results because there is no pain to prompt urgency.
The liver's silence is the disease's most dangerous feature. By the time NAFLD progresses to NASH, non-alcoholic steatohepatitis, where inflammation joins fat accumulation, and then to fibrosis, the window for dietary reversal has narrowed considerably. The disease is not irreversible at the fibrosis stage, but it is far harder to turn around than it was a decade earlier, when the only sign was a slightly bright liver on an ultrasound that the patient filed away and forgot.